Kochovska Slavica, Ferreira Diana H, Luckett Tim, Phillips Jane L, Currow David C
IMPACCT, Faculty of Health, University of Technology Sydney, Sydney, NSW, Australia.
Discipline Palliative and Supportive Services, Flinders University, Adelaide, SA, Australia.
Transl Lung Cancer Res. 2020 Aug;9(4):1699-1709. doi: 10.21037/tlcr.2019.12.18.
Lung cancer is the most common cancer and leading cause of cancer mortality globally. Lung cancer is associated with significant morbidity, with symptoms often being poorly managed, causing significant symptom burden for both patients and their family caregivers. In people with life-limiting illnesses including advanced cancer, palliative care has been effective in improving symptom control, physical and mental wellbeing, quality of life, and survivorship; with benefits extending to caregivers while in the role and subsequently. Earlier integration of palliative care within oncology may be associated with improved patient outcomes, and has been supported by two Lancet commissions and national guidelines. The evidence for its effectiveness, however, has been mixed across the cancer spectrum. The aim of this review was to evaluate the current evidence for the effectiveness of early integrated palliative care in improving outcomes for people with lung cancer and their caregivers. Meta-analyses were performed where studies used the same measure. Otherwise, synthesis used a narrative approach. Similar to other types of advanced cancer, this review reveals mixed evidence for the effectiveness of early referral to palliative care and for the effectiveness of individual palliative interventions for people with lung cancer and their caregivers. Evidence that on-demand palliative care is equally, if not more effective than palliative care that is routinely provided, raises the question whether initiation and provision of palliative care as part of multidisciplinary lung cancer care ought to be guided by an early referral or need-based referral. Better understanding of what constitutes palliative care when delivered to people with lung cancer and their caregivers will help delineate the correlation with reported outcomes for these populations.
肺癌是全球最常见的癌症,也是癌症死亡的主要原因。肺癌与严重的发病率相关,其症状往往难以得到有效控制,给患者及其家庭护理人员带来了巨大的症状负担。在包括晚期癌症在内的患有危及生命疾病的人群中,姑息治疗在改善症状控制、身心健康、生活质量和生存率方面已取得成效;其益处不仅惠及在职护理人员,对后续护理人员同样适用。在肿瘤学中更早地纳入姑息治疗可能会改善患者的治疗效果,这得到了《柳叶刀》的两个委员会和国家指南的支持。然而,其有效性的证据在整个癌症范围内参差不齐。本综述的目的是评估早期综合姑息治疗在改善肺癌患者及其护理人员治疗效果方面的现有证据。当研究使用相同的测量方法时,进行荟萃分析。否则,采用叙述性方法进行综合分析。与其他类型的晚期癌症类似,本综述揭示了关于早期转诊至姑息治疗的有效性以及针对肺癌患者及其护理人员的个体姑息治疗干预措施有效性的证据不一。按需提供姑息治疗即便不比常规提供的姑息治疗更有效,至少也是同样有效的,这引发了一个问题,即作为多学科肺癌护理一部分的姑息治疗的启动和提供,应该以早期转诊还是基于需求的转诊为指导。更好地理解为肺癌患者及其护理人员提供姑息治疗的构成要素,将有助于明确与这些人群报告的治疗效果之间的关联。